$250 | Single User
$500 | Site License
$750 | Global License

Shanghai Institute of Materia Medica Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 08-11-2018]

Published by Global Data: 08 Nov 2018 | 226723 | In Stock

Introduction

Summary

Shanghai Institute of Materia Medica Chinese Academy of Sciences (SIMM) is an educational research institute that provides research and development of traditional Chinese medicine. The institute offers solutions in the areas of drug discovery and drug development. It also offers studies of structure-activity relationships of bioactive substances, new chemical entities, pre-clinical evaluation and pharmaceutical development. SIMM develops drugs such as artemether, dimercaptosuccinic acid, and huperzine a, depsides salts, antofloxacin hydrochloride, and others. The institute carries out research in the areas of drug screening, pharmacology, medicinal chemistry, products chemistry, combinatorial chemistry, toxicology, pharmacokinetics and computer-aided drug design, among others. SIMM is headquartered in Pudong, China.

Shanghai Institute of Materia Medica Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Shanghai Institute of Materia Medica Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 08-11-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

    Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

    Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

    Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

    Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

    Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deal Details 10

    Partnerships 10

    Shandong Luoxin Pharma Enters into Agreement with Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Fudan University 10

    TechnoPhage Enters into Co-Development Agreement with Shanghai Institute of Materia Medica 11

    Shanghai Fosun Pharma Enters Into Co-Development Agreement With Shanghai Institute of Materia Medica To Develop Cancer Drug 12

    Licensing Agreements 13

    Servier Enters Into Licensing Agreement With Shanghai Institute Of Materia Medica 13

    Asset Transactions 14

    3SBio Acquires Patents For DJ5, Potential Renal Failure Therapy, From SIMM 14

    Shanghai Institute of Materia Medica Chinese Academy of Sciences - Key Competitors 16

    Shanghai Institute of Materia Medica Chinese Academy of Sciences - Key Employees 17

    Shanghai Institute of Materia Medica Chinese Academy of Sciences - Locations And Subsidiaries 18

    Head Office 18

    Recent Developments 19

    Government and Public Interest 19

    Jun 22, 2018: Scientists Make a Major Breakthrough in Signal Transduction of GPCR 19

    Product News 20

    Aug 30, 2018: Biomimetic strategy realizes imaging-guided treatment of Breast Cancer Metastasis 20

    Jan 03, 2018: Glucagon Receptor Structure Offers New Opportunities for Type 2 Diabetes Drug Discovery 21

    Appendix 22

    Methodology 22

    About GlobalData 22

    Contact Us 22

    Disclaimer 22

List Of Tables
in Shanghai Institute of Materia Medica Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 08-11-2018]

List of Tables

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Key Facts 2

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Deals By Therapy Area, 2012 to YTD 2018 8

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Shandong Luoxin Pharma Enters into Agreement with Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Fudan University 10

TechnoPhage Enters into Co-Development Agreement with Shanghai Institute of Materia Medica 11

Shanghai Fosun Pharma Enters Into Co-Development Agreement With Shanghai Institute of Materia Medica To Develop Cancer Drug 12

Servier Enters Into Licensing Agreement With Shanghai Institute Of Materia Medica 13

3SBio Acquires Patents For DJ5, Potential Renal Failure Therapy, From SIMM 14

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Key Competitors 16

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Key Employees 17

List Of Figures, Charts and Diagrams
in Shanghai Institute of Materia Medica Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 08-11-2018]

List of Figures

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Shanghai Institute of Materia Medica Chinese Academy of Sciences, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Additional Details

Publisher

Global Data

Publisher Information

Reference

226723 | GDPH204897D

Number of Pages

22

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) is a biopharmaceutical and hea...
09 Jan 2016 by Global Data USD $300 More Info
Shanghai Jiao Da Onlly Co., Ltd. (600530) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Jiao Da Onlly Co., Ltd. (SJDO) is a pharmaceutical company that develops, produces a...
09 Jan 2016 by Global Data USD $300 More Info
Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (600613) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (Shanghai Shenqi), formerly kno...
09 Jan 2016 by Global Data USD $300 More Info
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) is a biopharmaceutical and hea...
08 Nov 2015 by Global Data USD $300 More Info
Shanghai Jiao Da Onlly Co., Ltd. (600530) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Jiao Da Onlly Co., Ltd. (SJDO) is a pharmaceutical company that develops, produces a...
08 Nov 2015 by Global Data USD $300 More Info
Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (600613) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (Shanghai Shenqi), formerly kno...
08 Nov 2015 by Global Data USD $300 More Info
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (1349) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (FDZJ), a subsidiary of Shanghai Pharm...
08 Nov 2015 by Global Data USD $300 More Info
Shanghai Furen Industrial (Group) Co., Ltd. (600781) - Financial and Strategic SWOT Analysis Review
SummaryShanghai Furen Industrial (Group) Co., Ltd. (Shanghai Furen) is a pharmaceutical company. The...
08 Nov 2015 by Global Data USD $300 More Info
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Medical Equipment - Deals and Alliances Profile
SummaryShanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) is a biopharmaceutical and hea...
23 Oct 2015 by Global Data USD $250 More Info
Shanghai MicroPort Medical (Group) Co., Ltd. - Medical Equipment - Deals and Alliances Profile
SummaryShanghai MicroPort Medical (Group) Co., Ltd. (MicroPort), formerly MicroPort Medical (Shangha...
23 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Shanghai Institute of Materia Medica Chinese Academy of Sciences - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 08-11-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data